HemoSonics to Present on Novel Point of Care Platform at ISTH 2015 Congress

Charlottesville, VA – April 22, 2015 – HemoSonics, a medical device company developing a point-of-care diagnostic platform to guide the management of critical bleeding, today announced that two abstracts detailing its Quantra Dx platform were accepted for the International Society on Thrombosis and Hemostasis (ISTH) 2015 Congress. The conference will be held in Toronto on June 20 to 25. HemoSonics will present two posters:

Title: Development and Validation of an Assay for Intra-Surgical (or Peri-Operative) Management of Bleeding
Program Number: PO368-WED
Poster Session: Management of bleeding III
Date and Time of Poster Session: Wednesday, June 24 from 17:15 to 18:30
Authors: Ferrante EA, Blasier KR, Fischer TJ and Viola F

Title:  Assessment of a Test for Functional Fibrinogen in Whole Blood Using Ultrasound Technology Compared to Clauss Fibrinogen in Plasma
Program Number: PO203-TUE
Poster Session: Fibrinogen/fibrin/D-dimer II
Date and Time of Poster Session: Tuesday, June 23 from 18:00 to 19:30 
Authors: Blasier KR, Ferrante EA, Terrasi J, Fischer TJ, Viola F